VA prepares for psychedelic therapies to treat veteran PTSD and depression
S. 4220 — Veterans Health Administration Novel Therapeutics Preparedness Act · Filed by Tim Sheehy (R-MT) · 3 cosponsors · Introduced Mar 26, 2026 · Hearing held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a new Office of Novel Therapeutics within the Veterans Health Administration to prepare for and implement emerging mental health treatments—particularly psychedelic-assisted therapies under FDA review—for veterans with PTSD, depression, and other conditions. The office will develop clinical standards, training programs, implementation plans, and designate centers of excellence to ensure safe, coordinated rollout of these therapies across the VA system when approved.
Why we flagged it
The bill's core function is establishing organizational and clinical infrastructure within the VA to safely evaluate and implement emerging psychedelic-assisted and other novel therapies for veteran mental health conditions. It is a preparedness and governance measure, not a direct appropriation or treatment authorization.
What the text implies
- The bill does not authorize or approve any specific therapy; it creates the administrative apparatus to implement therapies once FDA-approved. This means the actual clinical rollout depends on separate FDA decisions and VA implementation decisions, creating a two-stage gate.
- The interagency coordination requirement (section 7396) with DEA, HHS, and FDA suggests potential scheduling/rescheduling of controlled substances (e.g., psilocybin, MDMA) may be anticipated; the bill does not assume these are already legal but prepares the VA to move quickly once they are.
The full analysis lists 4 implications of this text.
Who it affects
Veterans gain access to potentially life-changing emerging treatments with centralized safety oversight, standardized training, and dedicated infrastructure. The bill prioritizes patient safety, veteran input, and evidence-based implementation over rushed or inconsistent deployment.